Effect of zinc supplementation on blood glucose level in different age groups of diabetes type 2.

What Was Tested

Researchers studied Vitamin D, K2, Magnesium and Zinc in this randomized controlled trial publication.

Aim: The present study was designed to investigate the effects of zinc supplementation on blood glucose level in type-2 diabetic patients and determine the interaction between age and zinc supplementation on type-2 diabetic patients.

Why It Was Studied

Each group was further divided into 2 age categories Category 1 (30-50 years of age) and Category 2 (51-70 Years of age).

Who Took Part

The abstract describes 2 patients taking part.

By PubMed's age tags, the people studied were infants, young children, children, teenagers, young adults, adults, middle-aged adults and older adults.

How the Study Was Run

The design is described as randomized and placebo-controlled.

Random assignment meant chance, not the researchers, decided who got Vitamin D, K2, Magnesium and Zinc and who got the comparison, which limits bias.

A placebo (an inactive look-alike) gave the Vitamin D, K2, Magnesium and Zinc group a baseline to be compared against.

What Was Measured

Topics PubMed links to this paper include Zinc, Blood Glucose, Glycated Hemoglobin, Dietary Supplements and Diabetes Mellitus, Type 2.

Author keywords: 24-h-dietary recall, BMI, HbA1c, diabetes type 2 and fasting glucose level.

What This Means in Plain Language

The paper is a randomized and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc in 2 patients.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

The publication is from 2023 (Nutrition and health), a journal based in England.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.